Root Financial Partners’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
Other funds holding AVIR
BCM
Root Financial Partners's AVIR Position: Q3 2026 in Review
Root Financial Partners opened a new position in Atea Pharmaceuticals (AVIR) in Q3 2026: 116 shares worth $604. The stake represents ﹤0.01% of the portfolio and ranks #3151 among its holdings. This is a return to the name: Root Financial Partners previously reported a position in AVIR as recently as Q1 2026.
Root Financial Partners first reported a position in AVIR in Q1 2026 and has held it in 2 quarters since. 127 funds tracked by Wall St. Rank hold AVIR as of Q3 2026.
- Root Financial Partners held 116 shares of Atea Pharmaceuticals worth $604 as of Q3 2026.
- Atea Pharmaceuticals was a new Root Financial Partners position in Q3 2026.
- Atea Pharmaceuticals made up ﹤0.01% of Root Financial Partners's portfolio in Q3 2026, its #3151 holding.
- Root Financial Partners first reported a position in Atea Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- 127 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q3 2026.
Based on Root Financial Partners's 13F filing for Q3 2026, filed 21 Oct 2026.